"id","instanceType","label","description","name","uuid:ID","text"
"Objective_1","OBJECTIVE","","Main objective","OBJ1","efc12fb8-c0ad-464f-a043-77df0183a7e3","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"Objective_2","OBJECTIVE","","Safety","OBJ2","677875f9-7bf6-4c67-af79-6265c5ca6a3d","To document the safety profile of the xanomeline TTS."
"Objective_3","OBJECTIVE","","Behaviour","OBJ3","4f178b6f-bd74-4b69-8781-df51a7ad1c8f","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
